AdVia Therapeutics is a venture capital backed, discovery phase, life science company developing new gene therapies to treat genetic diseases for which treatment options are currently lacking. AdVia uses a proprietary discovery and delivery platform to identify and optimize new gene therapy vectors with the greatest potential for therapeutic development.